Pharmacological treatments in gambling disorder: A qualitative review

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Lupi, Matteo ^a   Martinotti, Giovanni ^a   Acciavatti, Tiziano ^a   Pettorruso, Mauro ^b   Brunetti, Marcella ^a   Santacroce, Rita ^a   Cinosi, Eduardo ^a   Di Iorio, Giuseppe ^a   Di Nicola, Marco ^b   Di Giannantonio, Massimo ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; ESCITALOPRAM; FLUVOXAMINE; HALOPERIDOL; LITHIUM; LITHIUM CARBONATE; MODAFINIL; MOOD STABILIZER; NALMEFENE; NALTREXONE; OLANZAPINE; OPIATE ANTAGONIST; PAROXETINE; PLACEBO; SERTRALINE; TOPIRAMATE; AMINO ACID RECEPTOR AFFECTING AGENT; NEUROLEPTIC AGENT;

BIPOLAR DISORDER; BRAIN REGION; DEPRESSION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMPULSE CONTROL DISORDER; META ANALYSIS (TOPIC); ORBITAL CORTEX; PATHOLOGICAL GAMBLING; POSITRON EMISSION TOMOGRAPHY; QUALITATIVE RESEARCH; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEROTONINERGIC TRANSMISSION; SYSTEMATIC REVIEW; BEHAVIOR, ADDICTIVE; FOOD AND DRUG ADMINISTRATION; GAMBLING; PATHOLOGY; PATHOPHYSIOLOGY; UNITED STATES;

ANTIPSYCHOTIC AGENTS; BEHAVIOR, ADDICTIVE; EXCITATORY AMINO ACID AGENTS; GAMBLING; HUMANS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84902131593     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/537306     Document Type: Review

References (53)

1. APA, Diagnostic and Statistical Manual 2013 5th Arlington, Va, USA American Psychiatric Association
2. Dell'Osso B., Altamura A. C., Allen A., Marazziti D., Hollander E., Epidemiologic and clinical updates on impulse control disorders: a critical review. European Archives of Psychiatry and Clinical Neuroscience 2006 256 8 464 475 2-s2.0-33745214485 10.1007/s00406-006-0668-0 (Pubitemid 46020521)
3. Villella C., Martinotti G., Di Nicola M., Cassano M., La Torre G., Gliubizzi M. D., Messeri I., Petruccelli F., Bria P., Janiri L., Conte G., Behavioural addictions in adolescents and young adults: results from a prevalence study. Journal of Gambling Studies 2011 27 2 203 214 2-s2.0-84856383244
4. Grant J. E., Kim S. W., Demographic and clinical features of 131 adult pathological gamblers. Journal of Clinical Psychiatry 2001 62 12 957 962 2-s2.0-0035658160 (Pubitemid 34007961)
5. Martinotti G., Andreoli S., Giametta E., Poli V., Bria P., Janiri L., The dimensional assessment of personality in pathologic and social gamblers: the role of novelty seeking and self-transcendence. Comprehensive Psychiatry 2006 47 5 350 356 2-s2.0-33746862897 10.1016/j.comppsych.2005.12.005 (Pubitemid 44188633)
6. Grant J. E., Potenza M. N., Ll Gioco D'azzardo Patologico-Una guida Clinica al Trattamento 2010 Springer
7. Pettorruso M., Martinotti G., Fasano A., Loria G., Di Nicola M., De Risio L., Ricciardi L., Conte G., Janiri L., Bentivoglio A. R., Anhedonia in Parkinson's disease patients with and without pathological gambling: a case-control study. Psychiatry Research 2014 215 2 448 452 10.1016/j.psychres. 2013.12.013
8. Grant J. E., Odlaug B. L., Schreiber L. R., Pharmacological treatments in pathological gambling. British Journal of Clinical Pharmacology 2014 77 2 375 381
9. Dell'Osso B., Allen A., Hollander E., Comorbidity issues in the pharmacological treatment of pathological gambling: a critical review. Clinical Practice and Epidemiology in Mental Health 2005 1, article 21 2-s2.0-33744499247 10.1186/1745-0179-1-21 (Pubitemid 44848732)
10. Angelucci F., Martinotti G., Gelfo F., Righino E., Conte G., Caltagirone C., Bria P., Ricci V., Enhanced BDNF serum levels in patients with severe pathological gambling. Addiction Biology 2013 18 4 749 751 2-s2.0-80055104475 10.1111/j.1369-1600.2011.00411.x
11. Hollander E., Decaria C. M., Finkell J. N., Begaz T., Wong C. M., Cartwright C., A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling. Biological Psychiatry 2000 47 9 813 817 2-s2.0-0034194232 10.1016/S0006-3223(00)00241-9 (Pubitemid 30254054)
12. Kim S. W., Grant J. E., Adson D. E., Chul Shin Y., Zaninelli R., A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. Journal of Clinical Psychiatry 2002 63 6 501 507 2-s2.0-0036088226 (Pubitemid 34680358)
13. Grant J. E., Potenza M. N., Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation. International Clinical Psychopharmacology 2006 21 4 203 209 2-s2.0-33646710977 10.1097/00004850-200607000-00002 (Pubitemid 43740297)
14. Saiz-Ruiz J., Blanco C., Ibáñez A., Masramon X., Gómez M. M., Madrigal M., Díez T., Sertraline treatment of pathological gambling: a pilot study. Journal of Clinical Psychiatry 2005 66 1 28 33
15. Kim S. W., Grant J. E., An open naltrexone treatment study in pathological gambling disorder. International Clinical Psychopharmacology 2001 16 5 285 289 2-s2.0-0034831124 (Pubitemid 32822448)
16. Grant J. E., Potenza M. N., Hollander E., Cynningham-Williams R., Nurminen T., Smits G., Kallio A., Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. The American Journal of Psychiatry 2006 163 2 303 312 2-s2.0-33645007938 10.1176/appi.ajp. 163.2.303 (Pubitemid 44480852)
17. Hollander E., Pallanti S., Allen A., Sood E., Rossi N. B., Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? The American Journal of Psychiatry 2005 162 1 137 145 2-s2.0-11844255363 10.1176/appi.ajp.162.1.137 (Pubitemid 40095683)
18. Fong T., Kalechstein A., Bernhard B., Rosenthal R., Rugle L., A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers. Pharmacology Biochemistry and Behavior 2008 89 3 298 303 2-s2.0-40849145375 10.1016/j.pbb.2007.12.025
19. McElroy S. L., Nelson E. B., Welge J. A., Kaehler L., Keck P. E. Jr., Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial. Journal of Clinical Psychiatry 2008 69 3 433 440 2-s2.0-42249090206 (Pubitemid 351549397)
20. Blanco C., Petkova E., Ibáñez A., Sáiz-Ruiz J., A pilot placebo-controlled study of fluvoxamine for pathological gambling. Annals of Clinical Psychiatry 2002 14 9 15 (Pubitemid 34538827)
21. Dannon P. N., Lowengrub K., Gonopolski Y., Musin E., Kotler M., Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. Clinical Neuropharmacology 2005 28 1 6 10 2-s2.0-13944282674 10.1097/01.wnf.0000152623.46474.07 (Pubitemid 40269711)
22. Chung S.-K., You I.-H., Cho G.-H., Chung G.-H., Shin Y.-C., Kim D.-J., Choi S.-W., Changes of functional MRI findings in a patient whose pathological gambling improved with fluvoxamine. Yonsei Medical Journal 2009 50 3 441 444 2-s2.0-67651176096 10.3349/ymj.2009.50.3.441
23. Grant J. E., Kim S. W., Potenza M. N., Blanco C., Ibáñez A., Stevens L., Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial. International Clinical Psychopharmacology 2003 18 243 249 (Pubitemid 36871876)
24. Black D. W., Shaw M., Forbush K. T., Allen J., An open-label trial of escitalopram in the treatment of pathological gambling. Clinical Neuropharmacology 2007 30 4 206 212 2-s2.0-34548445039 10.1097/wnf. 0b013e31803d357f (Pubitemid 47356717)
25. Zimmerman M., Breen R. B., Posternak M. A., An open-label study of citalopram in the treatment of pathological gambling. Journal of Clinical Psychiatry 2002 63 1 44 48 2-s2.0-0036152421 (Pubitemid 34113486)
26. Black D. W., Arndt S., Coryell W. H., Argo T., Forbush K. T., Shaw M. C., Perry P., Allen J., Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study. Journal of Clinical Psychopharmacology 2007 27 2 143 150 2-s2.0-34247176792 10.1097/01.jcp.0000264985.25109.25 (Pubitemid 46594929)
27. Dannon P. N., Lowengrub K., Musin E., Gonopolski Y., Kotler M., Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study. Journal of Clinical Psychopharmacology 2005 25 6 593 596 2-s2.0-27944462660 10.1097/01.jcp. 0000186867.90289.ed (Pubitemid 41669057)
28. Grant J. E., Kim S. W., Hollander E., Potenza M. N., Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology 2008 200 4 521 527 2-s2.0-52649104059 10.1007/s00213-008- 1235-3
29. Grant J. E., Suck W. K., Hartman B. K., A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. Journal of Clinical Psychiatry 2008 69 5 783 789 2-s2.0-45249097353 (Pubitemid 351838687)
30. Toneatto T., Brands B., Selby P., A randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of concurrent alcohol use disorder and pathological gambling. The American Journal on Addictions 2009 18 3 219 225 2-s2.0-67049165523 10.1080/10550490902787007
31. Rosenberg O., Dinur L. K., Dannon P. N., Four-year follow-up study of pharmacological treatment in pathological gamblers. Clinical Neuropharmacology 2013 36 2 42 45
32. Porchet R. I., Boekhoudt L., Studer B., Gandamaneni P. K., Rani N., Binnamangala S., Müller U., Clark L., Opioidergic and dopaminergic manipulation of gambling tendencies: a preliminary study in male recreational gamblers. Frontiers in Behavioral Neuroscience 2013 7 article 138
33. Grant J. E., Odlaug B. L., Potenza M. N., Hollander E., Kim S. W., Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study. British Journal of Psychiatry 2010 197 330 331
34. Di Nicola M., De Risio L., Pettorruso M., Caselli G., De Crescenzo F., Swierkosz-Lenart K., Martinotti G., Camardese G., Di Giannantonio M., Janiri L., Bipolar disorder and gambling disorder comorbidity: current evidence and treatment implications. In press
35. Pallanti S., Quercioli L., Sood E., Hollander E., Lithium and valproate treatment of pathological gambling: a randomized single-blind study. Journal of Clinical Psychiatry 2002 63 7 559 564 2-s2.0-0036077324 (Pubitemid 34787319)
36. Hollander E., Buchsbaum M. S., Haznedar M. M., Berenguer J., Berlin H. A., Chaplin W., Goodman C. R., LiCalzi E. M., Newmark R., Pallanti S., FDG-PET study in pathological gamblers: 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism. Neuropsychobiology 2008 58 1 37 47 2-s2.0-51049102164 10.1159/000154478
37. Black D. W., Shaw M. C., Allen J., Extended release carbamazepine in the treatment of pathological gambling: an open-label study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2008 32 5 1191 1194 2-s2.0-49849102499 10.1016/j.pnpbp.2008.02.013
38. Berlin H. A., Braun A., Simeon D., Koran L. M., Potenza M. N., McElroy S. L., A double-blind, placebo-controlled trial of topiramate for pathological gambling. World Journal of Biological Psychiatry 2013 14 2 121 128
39. Zack M., Poulos C. X., Parallel roles for dopamine in pathological gambling and psychostimulant addiction. Current Drug Abuse Reviews 2009 2 1 11 25 2-s2.0-70349784673 10.2174/1874473710902010011
40. CA, Kampman K. M., Lynch K. G., Plebani J. G., Pettinati H. M., Sparkman T., O'Brien C. P., A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Journal of Substance Abuse Treatment 2012 43 3 303 312
41. Goez H. R., Scott O., Nevo N., Bennett-Back O., Zelnik N., Using the test of variables of attention to determine the effectiveness of modafinil in children with attention-deficit hyperactivity disorder (ADHD): a prospective methylphenidate-controlled trial. Journal of Child Neurology 2012 27 12 1547 1552
42. Zack M., Poulos C. X., Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs. low impulsivity. Journal of Psychopharmacology 2009 23 6 660 671 2-s2.0-67651149760 10.1177/0269881108091072
43. Smart K., Desmond R. C., Poulos C. X., Zack M., Modafinil increases reward salience in a slot machine game in low and high impulsivity pathological gamblers. Neuropharmacology 2013 73 66 74
44. Zack M., Poulos C. X., Amphetamine primes motivation to gamble and gambling-related semantic networks in problem gamblers. Neuropsychopharmacology 2004 29 1 195 207 2-s2.0-0347318190 10.1038/sj.npp.1300333 (Pubitemid 38068030)
45. Pettorruso M., Conte G., Righino E., Di Cesare A., Chiappini S., Testa R., Janiri L., Glutamatergic strategies in the treatment of pathological gambling: a pilot study. European Psychiatry 2013 28 Supplement 1, article 2876 1
46. Olive M. F., Cleva R. M., Kalivas P. W., Malcolm R. J., Glutamatergic medications for the treatment of drug and behavioral addictions. Pharmacology Biochemistry and Behavior 2012 100 4 801 810 2-s2.0-84855534956 10.1016/j.pbb.2011.04.015
47. Grant J. E., Kim S. W., Odlaug B. L., N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biological Psychiatry 2007 62 6 652 657 2-s2.0-34548150512 10.1016/j.biopsych.2006.11.021 (Pubitemid 47314380)
48. Grant J. E., Chamberlain S. R., Odlaug B. L., Potenza M. N., Kim S. W., Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study. Psychopharmacology 2010 212 4 603 612 2-s2.0-78651323502 10.1007/s00213-010-1994-5
49. Thomas A., Bonanni L., Gambi F., Di Iorio A., Onofrj M., Pathological gambling in parkinson disease is reduced by amantadine. Annals of Neurology 2010 68 3 400 404 2-s2.0-77956359289 10.1002/ana.22029
50. Pettorruso M., Martinotti G., Di Nicola M., Onofrj M., Di Giannantonio M., Conte G., Janiri L., Amantadine in the treatment of pathological gambling: a case report. Front Psychiatry 2012 3 article 102
51. Black D. W., McNeilly D. P., Burke W. J., Shaw M. C., Allen J., An open-label trial of acamprosate in the treatment of pathological gambling. Annals of Clinical Psychiatry 2011 23 4 250 256 2-s2.0-84858314840
52. Dannon P. N., Rosenberg O., Schoenfeld N., Kotler M., Acamprosate and baclofen were not effective in the treatment of pathological gambling: preliminary blind rater comparison study. Front Psychiatry 2011 2 article 33
53. Achab S., Khazaal Y., Psychopharmacological treatment in pathological gambling: a critical review. Current Pharmaceutical Design 2011 17 14 1389 1395 2-s2.0-79959934411 10.2174/138161211796150774